|
|||||
|
|
Identification of a novel PDGFRA point mutation at p.P6L as a potential molecular target of imatinib in an eosinophilia patient showing genetic heterogeneity |
|
| Authors: | Miaomiao Zhao Qiuling Wu Linghui Xia Min Zhang Jianqing Yang Yaya Li |
| Affiliation: | 1. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;2. R&3. D department, Righton Biotechnology Co., Ltd, Shanghai, China |
| Abstract: | |
| Keywords: | Eosinophilia bone rupture FIP1L1-PDGFRA PDGFRA RT-PCR NGS Imatinib |